Global Parenteral Drugs Packaging Market to reach USD XXX billion by 2027.Global Parenteral Drugs Packaging Market is valued approximately at USD XXX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2021-2027. Parenteral drugs have to be given through the route systems of the body unlike digestive systems. that is, it is directly given into the veins through syringe instead of directly consuming it manually. These come in plastics and glasses with different quantities available for the end users, as per their needs and preferences. Growing demand for vaccines, therapeutic and other supplements and increasing healthcare expenditure in the economy of the world are factors contributing to the market growth. For instance: according to Statista, in India, the healthcare expenditure is projected to touch USD 372 billion, by the year end 2022 from USD 160 billion, in the year 2017 whereas the per capita health care expenditure amounted to USD 21.63, in the year 2018. The developed and well-to-do states such as Maharashtra and Uttar Pradesh spent approximately USD 1.62 to USD 2.44 billion, in the same year Thus, with an increase in healthcare expenditure, growth in the Parenteral drugs market is expected in the long run. However, requirement of big investment capital in setting up of the manufacturing units and Competition from the existing and new pharmaceutical industries impedes the market growth over the forecast period of 2021-2027. Also, Increasing R&D investments from various sectors and changes in the government laid guidelines and policies which are likely to boost the market growth in the forecast period.

The regional analysis of global Parenteral Drugs Packaging market includes regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World for analysis and estimation, North America is the significant region across the world in terms of market share owing to heavy expenditure in the healthcare sector Whereas, Asia Pacific is anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as well-established firms in the region coupled with the economic healthcare expenditure would create lucrative growth prospects for the Parenteral Drugs Packaging market across Asia Pacific region.

Major market player included in this report are:

Ypsomed Holdings AG
Gerresheimer AG
SiO2 Medical Products
Schott AG
Ompi Stevanato Group
Becton Dickinson and Company
MeadWestvaco Company
Unilife Corporation Inc
West Pharmaceutical Services Inc
Terumo Corporation



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product type:
Pre-filled Syringes & Cartridges
Vials
Bags
Ready to use Systems
Ampoules
By Material type:
Plastic
Glass
By Packaging type:
Large Volume Parenteral (LVP)
Small Volume Parenteral (SVP)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Parenteral Drugs Packaging Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors